Reaction Details Report a problem with these data
Target
Egl nine homolog 1 [182-426]
Ligand
BDBM373666
Substrate
n/a
Meas. Tech.
PHD enzymatic assay
IC50
200±n/a nM
Citation
 Rabinowitz, MH; Rosen, MD; Tarantino, KT; Venkatesan, H 4-Aminoquinazolin compounds as prolyl hydroxylase inhibitors US Patent  US10246442 Publication Date 4/2/2019 
Target
Name:
Egl nine homolog 1 [182-426]
Synonyms:
C1orf12 | EGLN1 | EGLN1_HUMAN | HIF-1alpha-PHD2
Type:
Enzyme Catalytic Domain
Mol. Mass.:
27392.37
Organism:
Homo sapiens (Human)
Description:
Q9GZT9[182-426]
Residue:
245
Sequence:
NGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF
  
Inhibitor
Name:
BDBM373666
Synonyms:
1-(6-(Cyclohexyloxy)-7-chloro-4-morpholinoquinazolin-2-yl)-1H-pyrazole-4-carboxylic acid; | US10246442, Example 136 | US10975062, Example 136
Type:
Small organic molecule
Emp. Form.:
C22H24ClN5O4
Mol. Mass.:
457.91
SMILES:
OC(=O)c1cnn(c1)-c1nc(N2CCOCC2)c2cc(OC3CCCCC3)c(Cl)cc2n1
Structure:
Search PDB for entries with ligand similarity: